Oswald Reitz, Ronda, PhD
Presentation(s):
Why Provide DBT: Latest Updates on Effectiveness and Clinical Applications
Presentation(s):
Why Provide DBT: Latest Updates on Effectiveness and Clinical Applications
Presentation(s):
Dr. Kristin Sohl, MD, FAAP is a Professor of Clinical Child Health at the University of Missouri, Executive Director of ECHO Autism and Scientific Advisor for the National Institutes of Neurologic Disorders and Stroke, and Medical Director for MU Missouri Telehealth Network and the MU Office of Continuing Medical Education. She is a pediatrician with extensive experience in medical diagnosis, evaluation, and treatment of children with a concern of autism and other neurodevelopmental disorders. Dr. Sohl is regarded as an expert in quality and process improvement particularly for comprehensive autism diagnostic and longitudinal services. She is the founder of ECHO Autism, an innovative framework to increase community capacity to care for children with autism. It is viewed as a national model in expanding autism diagnosis and treatment to underserved and rural populations. The ECHO Autism team has established partnerships with other children’s hospitals and autism centers in more than 40 locations in the United States and 15 international locations. Dr. Sohl is a tireless advocate for children and enjoys engaging other physicians in being a voice for children’s health. She is the President of the American Academy of Pediatrics, Missouri Chapter. She completed medical school and pediatric residency at the University of Missouri.
Presentation(s):
Presentation(s):
Rachel Winograd, PhD, is a licensed clinical psychologist, Associate Professor, and Director of Addiction Science at the University of Missouri, St. Louis. Her clinical, research, program development, and advocacy interests revolve around interventions to save and improve the lives of people who use drugs. Currently, she serves as Principal Investigator of the Addiction Science, Practice, Implementation, Research, & Education (ASPIRE) Lab in the Department of Psychological Sciences and directs a grant-funded Addiction Science team of 25 engaged staff, faculty, and students within the Missouri Institute of Mental Health. Her scholarly and implementation work is funded by SAMHSA, NIDA, CDC, the Missouri Foundation for Health, and Missouri’s Opioid Pharmaceutical Settlements through the Missouri Departments of Mental Health and Health & Senior Services. Dr. Winograd and her teams efforts focus on improving overdose prevention, community health, and treatment and recovery services by expanding access to medical treatment, innovative harm reduction strategies, and person-centered approaches to drug use and addiction.
Presentation(s):
From Research to Practice: Diverse Approaches to Understanding and Addressing Substance Use
Presentation(s):
Ethical Approaches to Vicarious Trauma, Self‑Care, and Professional Conduct- Part 1